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 ABSTRACT 
 
Microscopic tissue damage can occur in bone as a result of an isolated overload 
leading to reduces bone strength under subsequent loads. In addition, microscopic 
tissue damage is believed to stimulate bone resorption and bone loss.  Microscopic 
tissue damage in bone is most commonly measured in two-dimensional sections using 
stereology techniques. Stereology techniques are accurate but can have limited 
precision.  Previous studies have presented guidelines for adequate sampling of 
naturally occurring microcracks in cortical bone, but such guidelines have not been 
presented for cancellous bone and have not addressed other forms of microscopic 
tissue damage (i.e. diffuse damage).  Here a statistical model is presented that can be 
used to design studies in which microscopic tissue damage in cancellous bone is a key 
study outcome.   
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1.0 INTRODUCTION 
Microscopic tissue damage can form in bone tissue during normal activities or 
isolated overloading events. Microscopic tissue damage has the potential to reduce 
bone strength under subsequent loading [1] and has been shown to stimulate bone 
resorption in vivo [2].  While a great majority of studies of microscopic tissue damage 
have concentrated on naturally occurring microdamage in otherwise normal bone 
tissue, examination of microscopic tissue damage generated during biomechanical 
testing in vitro can provide information regarding failure processes in bone tissue. 
Induced microscopic tissue damage can provide insight of how failure processes are 
influenced by aspects of bone that can be altered by drug treatments. Possible 
parameters that can be altered with drug treatments include local bone morphology 
(trabecular microarchitecture, resorption cavities, etc.) or local variation in tissue 
properties (osteons, cement lines, tissue degree of mineralization, collagen cross-
linking, etc.).  
The current standard for measuring microscopic tissue damage in bone is bulk 
stain followed by sectioning (50-200 µm thick) and quantification using stereology 
techniques.  Microscopic tissue damage is characterized in two forms: 1) microcracks 
(80 - 150 µm in length) measured as the crack density (Cr.Dn, number of cracks per 
unit bone cross-sectional area); and 2) diffuse damage, a region of diffuse staining 
measured through point counting and expressed as a proportion of the total amount of 
bone (DV/BV).  The term “microdamage” is used to describe both microcracks and 
diffuse damage.  Recently, three-dimensional images of bone and microdamage have 
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been developed using micro-computed tomography (with radio-opaque stains) as well 
as with serial milling (using fluorochrome stains) [3-6].   
A challenge to understanding the contribution of microdamage to mechanical 
failure of cancellous bone is that measures of microdamage are highly variable [7].  
Studies of microdamage generated in vitro in cancellous bone specimens often show 
coefficient of variations (SD/Mean) in excess of 0.60 (Table 1).  The large variability 
in microdamage limits statistical power.  For example, a measurement with a 
coefficient of variation of 0.60 would require 143 specimens per group to detect a 30% 
difference between two groups using a t-test (α = 0.05 and statistical power = 0.90).  
As 143 specimens per group is not feasible in biomechanical studies (few 
biomechanical studies use more than 30 specimens), methods of improving statistical 
power by altering the measurement approach (number of sections, cross-sectional area 
examined) or study design (varying the number of donors, number of specimens per 
donor, and the amount of applied mechanical load) are needed to better understand the 
relationship between microdamage, mechanical performance, and mechanical failure 
in cancellous bone.  Improvements in measurement approach reduce the contribution 
of measurement error to variance while alterations in study design can make it 
possible to obtain more insight from an experiment for a given number of specimens.  
It is not known exactly how measurement technique influences measurement error in 
cancellous bone nor is it known how study design influences the ability to detect the 
effects of an experimental stimulus. 
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Compilation of Studies that Report Microscopic Tissue Damage Measured Using 
Two-Dimensional Sections 
Table 1. Microscopic tissue damage generated by a controlled mechanical load is 
shown. Each test group in the experiment is reported in separate line. Most studies 
showed coefficients of variation (CV = SD/Mean) greater than 0.50. Values that were 
not expressly reported by the authors were left as NR.*11 different groups were tested 
in this study, the median value is reported. ^22 different groups were tested in this 
study, the median value is reported. 
 
Author 
(Year) Technique 
Sections 
Analyzed 
Area 
Analyzed 
Damage 
Fraction ± SD 
CV  
O’Neal 
(2010) 
[16] 
Damage Incidents  6 NR 
0.74 ± 0.14 0.19 
0.43 ± 0.24 0.56 
Dux 
(2010)  
 [17] 
Stereological Point  
Counting on Slides  2 42 mm
2 
0.16 ± 0.20 1.26 
0.26 ± 0.31 1.20 
Nagaraja 
(2007)  
 [18] 
Automatic 
Segmentation  4 32 mm
2 
0.0023 ± 0.0012 0.53 
0.0018 ± 0.0012 0.68 
0.011 ± 0.0051 0.46 
0.010 ± 0.0022 0.21 
Nagaraja 
(2005) 
 [19] 
Stereological Point  
Counting on Images  4 NR 
0.011 ± 0.0073 0.61 
0.010 ± 0.0031 0.31 
Wang 
(2006) 
 [20] 
Tracing of Image  2 NR 
0.0046 ± 0.0017 0.38 
0.0044 ± 0.0014 0.31 
0.0046 ± 0.0017 0.37 
Wang 
(2005) 
[21] 
Tracing of Image  2-4 84 mm2 0.0045 ± 0.0014 0.31 
Moore 
(2003) 
[22] 
Tracing of Image  NR 118 ± 40 mm2 0.0040 ± 0.0033 0.82* 
Moore 
(2002) 
[23] 
Tracing of Image  3-5 301 ± 63 
mm2 
0.018 ± 0.13 0.72^ 
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Compilation of Studies that Report Microscopic Tissue Damage Measured Using 
Three-Dimensional Analysis Techniques 
Table 2: Microscopic tissue damage reported in previous studies in which a controlled 
mechanical load was applied in vitro and three-dimensional measures of microdamage 
were used is shown. Each test group in the experiment is reported in separate line. 
Most studies showed coefficients of variation (CV = SD/Mean) greater than 0.50. 
Values that were not expressly reported by the authors were left as NR. 
 
Author 
(Year) 
3D 
Technique Voxel Size 
Volume 
Analyzed 
Damage Fraction 
± SD CV  
Wang 
(2007) 
[4] 
BaSO4 Stain 
with µCT 
10 x 10 x 10 
µm 125 mm
3 
0.045 ± 0.029 0.65 
0.012 ± 0.0081 0.66 
Tang 
(2010) 
[10] 
Lead Uranyl-
Acetate with 
µCT 
10 x 10 x 10 
µm 64 mm
3 
0.15 ± 0.022 0.14 
0.14 ± 0.018 0.13 
Karim 
(2011) 
[11] 
Lead Uranyl-
Acetate with 
µCT 
17.5 x 17.5 x 
17.5 µm 8 mm
3 
0.059 ± 0.061 1.03 
0.026 ± 0.025 0.99 
0.0026 ± 0.0038 1.46 
Bigley 
(2008) 
[5] 
Serial Block-
Face Imaging 9 x 9 x 5 µm
3 NR 0.047 ± 0.021 0.45 
Slyfield 
(2012) 
[6] 
Serial Block-
Face Imaging 
2.8 x 2.8 x 5 
µm3 
190 mm3 0.77 ± 0.33 0.43 
 
Martin and colleagues presented a statistical model to explain how the number 
of sections taken from each specimen and cross-sectional area examined in each 
section influences measurement variance in cortical bone [8].  The study provided key 
information regarding how to quantify naturally occurring microdamage in cortical 
bone but did not address quantification of diffuse damage or quantification in 
cancellous bone and did not explicitly report statistical power.  Here, the work by 
Martin and colleagues has been generalized to examine diffuse damage measures, and 
allow for simulation of all densities of bone (both cancellous as well as cortical bone).  
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The overall goal of this line of work is to understand the relationship between 
microscopic tissue damage and cancellous bone biomechanical performance.  
Specifically in this study the following questions were asked: (1) how does the cross-
sectional area examined in each section, the number of sections examined, and the 
amount of microdamage in the specimen affect measurement error; (2) how do 
changes in study design (number of donors, number of specimens per donor, 
distribution of specimens in a study) affect the ability to describe the relationship 
between the amount of microdamage and applied mechanical load (or other 
predictor)? The current work differs from prior work in that it is applied to cancellous 
bone, it considers measures of diffuse damage, and addresses methods of allocating 
specimens among experimental groups that are based on the magnitude of a stimulus 
(in this case applied mechanical load).  
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2.0 THEORY 
Statistical simulation is a common approach used to design studies or calculate 
statistical power when closed form solutions are not available. To perform such an 
analysis one first uses pilot data to describe the statistical distribution for the 
population of interest and then simulates an experiment by randomly selecting 
quantitative data from that distribution.  By repeating the simulation thousands of 
times a distribution of possible results for an experiment is achieved.  By modifying 
parameters such as number of sections analyzed or number of specimens, it can 
determined how these parameters influence the distribution of possible results and 
characterize the likelihood that a proposed experimental design will detect differences 
between groups.  
 
2.1 Model 1 – Measurement Error Analysis 
In most studies microdamage in bone is measured in a finite number of two-
dimensional sections collected from each specimen. Measurement variability can 
occur because the entire sample is not measured and only specific regions of each 
section are examined.  To determine how measurement technique (cross-sectional area 
per section, number of sections) influences measurement error, a statistical model 
written for use with R (www.r-project.org, see Appendix 2) was implemented.  The 
model assumes a population distribution of microdamage across individuals defined 
by the median and the intra-95% range (RS95, the ratio of the 97.5th percentile to that 
of the 2.5th percentile).  The median and RS95 are analogous to the mean and standard 
deviation but characterize non-normal distributions. 
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Following the work by Martin and colleagues [8], microdamage within a 
specimen cross-section was simulated using a Poisson distribution: 
 ( )
!
µ µ−=
k
P k e
k
 (1) 
where P(k) is the probability that a cross-section contains k instances of microdamage 
(cracks or a patch of diffuse damage) and µ is the mean number of instances of 
microdamage per cross-section. The model assumes measurements are made on each 
section accurately (i.e. there is no observer error in measurement), that each observed 
instance of microscopic tissue damage is independent, and that microdamage is 
equally likely to occur throughout the specimen. The statistical model considers 
measurement of crack density (Cr.Dn, microcracks per unit bone area) separately from 
that of diffuse damage to account for differences in variance due to the fact that crack 
density is a ratio of a discrete variable (the number of cracks within a specimen) to a 
continuous variable (the bone area) while diffuse damage is determined as the ratio of 
two continuous variables (DV/BV). 
The model simulates the measurement of microcracks by first randomly 
selecting a crack density value from the population distribution to represent the true 
mean crack density in one specimen (True.Dx, Figure 1).  The true mean crack density 
of that specimen is then used to create a Poisson distribution of the number of cracks 
observed in a section (Equation 1, with a mean value µ = True.Dx).  The average 
number of microcracks per unit area observed within one cross-section is calculated 
and stored in the model.  The simulation is then repeated for each cross-section 
examined within the specimen and the results for each cross-section are averaged and 
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reported as the measured crack density (Meas.Dx) for the specimen.  Measurement 
error is calculated as the ratio of the measured crack density in the specimen and the 
true crack density ( Meas.DxError
True.Dx
= , a value of 1.0 signifies there is no measurement 
error). The whole process is repeated 5000 times (simulating analysis of 5000 
specimens) and the 2.5% and 97.5% quantiles of the measurement error are reported 
(Figure 1). A similar approach is used to examine diffuse damage, however, a Poisson 
distribution models discrete events, thus an extra parameter is necessary for the diffuse 
damage simulation (M.RS95). The M.RS95 parameter adjusts the diffuse damage 
measure such that it can be represented by a Poisson distribution. Measurement 
techniques (number of sections, cross-sectional area per section, etc.) that result in the 
smallest intra-95% range of measurement error are most accurate.  
Three-dimensional measurements of microdamage (radio-opaque stains with 
micro-CT or fluorescent stains with serial milling) are simulated by considering each 
cross-section in the three-dimensional image to be an individual section. As an 
example we consider a cylinder of cancellous bone that is 8mm in diameter and 5mm 
in length (a typical specimen for mechanical testing in our laboratory) which is imaged 
in three-dimensions using 1000 cross-sections (5 µm in thickness), each with a cross-
sectional area of 50.27 mm2.  
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Schematic Representing the Measurement Error Analysis Software for 
Measuring Crack Density 
 
Figure 1: The method of simulating microdamage is illustrated. A population 
distribution of specimens based on previous experiments is assumed. From that 
population distribution, a mean crack density value (True.Dx) is randomly selected 
and used to define the Poisson distribution which simulates each microcrack observed 
in a cross-section. The number of microcracks for each cross-section is averaged for 
the number of sections analyzed. The average estimated crack density (Meas.Dx) is 
compared to the real crack density (True.Dx) to determine measurement error 
(Meas.Dx/True.Dx). The simulation is repeated 5000 times and the intra-95% range of 
measurement error is reported. 
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2.2 Model 2 – Number and Distribution of Study Groups 
Measurement of microdamage is often required to compare two or more 
experimental groups and/or identify relationships between a stimulus and the resulting 
amount of microdamage.  A common experimental design is to have two or more 
experimental groups, each experiencing a different magnitude of stimulus.  To identify 
the most attractive distribution of number of donors, number of specimens per donor, 
and magnitude of stimulus a statistical model written for use with R (www.r-
project.org, see Appendix 2) was implemented.  In the current analysis applied 
mechanical strain was the only stimulus considered.  It is important to note that by 
modifying specific parameters, however, the same software can be used for any 
independent parameter (donor age, microarchitecture, etc.).  When there are only two 
experimental groups, the analysis is equivalent to a t-test (Figure 2) [9]. 
Schematic of a T-Test Implemented as an Ordinary Linear Regression 
Model 
 
Figure 2. A graphical representation of a t-test implemented as an ordinary linear 
model is shown.  Two tests are represented, one with a 60% increase in the Treatment 
Group (circles) and one with a 10% increase in the Treatment Group (diamonds). The 
y-intercept (log(B0)) is the mean amount of microdamage in the control group and the 
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slope of each line (log(B1)) is the difference between means. A steeper slope indicates 
a larger difference between groups. 
 
Over a range of applied mechanical strains (0% applied strain – 2.25% applied 
strain), the relationship between microdamage and applied strain is exponential [3]. 
The following equation was then used to express the exponential relationship between 
the applied strain and the amount of microdamage present in cancellous bone: 
 
AppliedStrain
Ref.Strain
0 1*
 
 
   = 
 
DV B B
BV
 (2) 
where B0 is the mean amount of damage in the unloaded control group (y-intercept of 
the curve fit) and B1 is the increase in damage volume for a particular applied strain 
(the slope of the relationship on a log-log axis). The reference value (Ref.Strain) is an 
arbitrary scaling factor and was chosen to be within our applied strain range (2% 
applied strain). By applying a logarithmic transformation we get the following linear 
relationship: 
 ( ) ( )0 1
AppliedStrainlog log log *
Ref.Strain
   = +   
   
DV B B
BV
 (3) 
For the simulations, the statistical power for a study design was determined by 
assuming a population distribution and simulating thousands of individual 
experiments using the following steps: First, population distributions for the 
parameters B0 and B1 are assumed (using preliminary data and/or previous experience) 
and expressed in terms of median and RS95.  Measurements in one individual are 
simulated by selecting values for B0 and B1 from the population distributions at 
random.  The selected B0 and B1 values define the true relationship between applied 
strain and microdamage in one individual (True.B0, True.B1, respectively). Once B0 
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and B1 are determined, Equation 2 is used to express the amount of microdamage 
(True.Dx) expected for an applied mechanical strain. The True.Dx parameter 
represents the damage volume if the donor sample could be perfectly analyzed. Since, 
as we have seen from Model 1, no measurement is perfect, noise is added to simulate 
an actual experiment (see Appendix 1 for details). The predicted damage volume 
(Meas.Dx) is determined for each experimental group and used to determine the 
measured relationship between applied mechanical strain and microdamage in the 
simulation (Meas.Rel). The simulation is repeated 5000 times and a distribution for B0 
and B1 are determined (Meas.B0 and Meas.B1, respectively) (Figure 3). 
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Schematic Representing the Analysis Software for Determining the Number and 
Distribution of Experimental Groups when Measuring the Relationship 
Betweenn Applied Strain and the Accumulation of Microdamage 
 
Figure 3. A depiction of the simulation process for the regression model experiments 
is shown. The model begins with an assumed relationship between the stimulus 
(mechanical loading) and response (microdamage accumulation). Population 
distributions are then defined for each coefficient in the relationship. The coefficient 
values are then randomly selected from the defined population distributions (True.B0 
and True.B1, respectively) to create the true exponential relationship of a donor 
(True.Rel). Based on the measurement error values from model 1 and previous 
experiments, noise is added to the true value at each experimental group. An 
exponential fit for the data is calculated (Meas.Rel) to estimate the B0 and B1 
coefficients (Meas.B0 and Meas.B1, respectively). The process is then repeated 5000 
times to represent a full population of experiments and a distribution of the estimated 
B1 is reported. 
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A total of 5000 experiments measuring microdamage are simulated. The 95% 
confidence interval of the parameter B1 is determined.  The parameter B1 expresses the 
slope of the model in Equation 2 and is equal to one if there is no difference between 
two groups or no relationship between the independent and dependent variables in the 
case of more than one experimental group.  Statistical power expresses the probability 
of detecting a difference in B1 from the null value for a given value of α (in our case α 
= 0.05).  In the examples described below, a value of B1 = 5 is used as the null value 
rather than the more traditionally used value of B1 = 1. Values of B1 exceeding 5 
indicate not only that the slope of the curve significantly different from one (i.e. a 
trend exists), but that there is a convincing relationship between applied mechanical 
strain and the accumulation of microdamage.  Statistical power was calculated using 
the hypothesis that B1 > 5 with α = 0.05.  Statistical power identified with this more 
conservative null hypothesis will be referred to as ‘essential statistical power’ through 
the remaining portion of the thesis. 
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3.0 RESULTS 
3.1 Model 1 – Measurement Error Analysis 
3.1.1 Cross-sectional Area  
The cross-sectional area examined in each two-dimensional section varies 
considerably among laboratories and studies (range 30 - 300 mm2) and there are no 
clear recommendations for such analysis examining microdamage in cancellous bone 
(Table 1). With regard to crack density, increases in cross-sectional area per section 
reduced measurement error (as indicated by the reductions in size of the 95% 
confidence interval, Figure 4). However, increasing the cross-sectional area per 
section beyond 40mm2 had only a minor effect on measurement error. The 
measurement error of diffuse damage was not affected by alterations in cross-sectional 
area per section. 
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The Effect of Cross-sectional Area and Bone Volume Fraction on Measurement 
Error for Crack Density 
 
Figure 4.  The intra - 95% range of measurement error for crack density is illustrated 
as the distance between points in the vertical direction. Increasing the cross-sectional 
area examined in each specimen reduces the range, however, when the cross-sectional 
area analyzed is increased beyond 40mm2, only minor reductions in the range of 
measurement error occur. 
 
3.1.2 Number of Sections 
Published studies of microdamage in cancellous bone use 2 to 6 sections per 
specimen (Table 1), and there is no clear consensus on the number of sections to 
analyze. The results of the simulations show that increasing the number of sections 
reduces the measurement error for both crack density and diffuse damage (Figure 5).  
However, analyzing more than three sections per specimen provides relatively little 
improvement on measurement error (insets of Figure 5).  Although there is limited 
improved, the measurement error can be reduced to approximately 10% when 
analyzing over 200 sections of the specimen (as seen in three-dimensional imaging).  
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Thus, unless the measurement method is extremely inexpensive in terms of labor (i.e. 
three-dimensional automated approaches) analyzing more than three sections provides 
little benefit in terms of reducing the error.  
The Effect of the Number of Sections and Bone Volume Fraction on 
Measurement Error for Crack Density and Diffuse Damage Volume 
  
Figure 5. Increasing the number of sections reduces measurement error of crack 
density (left) and damage volume (right), as indicated by a thinning of the intra - 95% 
range. Increasing the number of sections beyond 3, however, will have little 
improvement on measurement error (see inset). Measurement error for diffuse damage 
is the same for every bone volume fraction. 
 
3.1.3 Bone Volume Fraction 
Because microdamage may only be present in bone tissue, specimens with 
greater bone volume fraction should have a greater amount of bone and microdamage 
to sample, potentially reducing measurement error. With regard to crack density, our 
simulations suggest that specimens with less bone volume fraction are expected to 
have increased measurement error as indicated by an increase in the intra-95% range 
of measurement error (Figures 4 and 5).  However, even in more porous specimens 
(BV/TV = 10%) increasing the total cross-sectional area per specimen examined 
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beyond 120 mm2 (3 sections of 40 mm2 analyzed) has little effect on reducing 
measurement error (Figure 4). Hence, there is little advantage to examining more than 
120 mm2 of each specimen in either low-density or high-density cancellous bone. 
There was no effect of bone volume fraction on the measurement error of diffuse 
damage in our simulations.  
 
3.1.4 Three Dimensional Measurement of Microdamage 
Three-dimensional measures of microscopic tissue damage in cancellous bone 
have recently been demonstrated.  These include the use of a radio-opaque stain such 
as lead-uranyl acetate [3, 10, 11] or barium sulfate [4] with micro-computed 
tomography and the use of standard fluorochrome stains and three-dimensional 
fluorescence imaging using serial milling [5, 6].  As these methods involve sampling 
the entire specimen, they can remove most of the variance associated with 
measurement technique (some measurement variance associated with image noise and 
thresholding will remain and is not addressed here). Increases in the number of 
sections to 1000 and cross-sectional area analyzed to 50.27mm2 result in a 
measurement error of less than 10% (insets of Figure 5). 
 
3.1.5 Amount of Microdamage  
Martin and colleagues implied that the proportion of specimens without 
microdamage (‘crack-less’ specimens) in a study causes increases in measurement 
variance [8]. However, Martin and colleagues concentrated on naturally occurring 
microdamage, which is present in relatively small amounts, and did not consider 
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microdamage generated by controlled loading in vitro, which can be much greater in 
magnitude. In a Poisson distribution, the variance is equal to the mean. This implies 
that any increase in the mean amount of microdamage leads to a proportional increase 
in variance (in agreement with Martin and colleagues). However, the relative size 
between the mean and variance remains the same. Since measurement error in this 
type of study is the ratio of the estimated value over the true value, measurement error 
is not influenced by changes in mean microdamage. Hence, measurement error is not 
affected by changes to the amount of microdamage in a specimen if the same method 
of specimen analysis (number of sections, cross-sectional area per section, etc) 
remains the same. Therefore, the same sampling techniques can be used for 
experimental groups with low- and high- amounts of microdamage. 
 
3.2 Model 2 – Number and Distribution of Experimental Groups 
 One strategy for understanding the relationship between the amount of 
microdamage and a predictor (such as magnitude of applied mechanical strain) is to 
use multiple experimental groups distributed across a range of predictor values [3, 11, 
12].  A regression model is used to determine the relationship between the predictor 
and the amount of microdamage. Such a study design requires a selection of the 
number of experimental groups (where each group experiences a different amount of 
applied mechanical strain) and number of specimens per group. Simulations of 
different study designs (number of donors, number of specimens per donor, and 
distribution of specimens across a range of applied mechanical loading) are performed 
using the population distributions found in previous studies (Table 1, Table 2) and the 
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results from the Model 1 experiments.  Two types of experiments were simulated: The 
first set of simulations uses multiple specimens from each donor to take advantage of 
repeated measures of each donor.  In this first simulation model a study design with 5 
experimental groups and 3 specimens per group requires only 3 donors (5 specimens 
from each donor for a total of 15 specimens). This first type of simulation is referred 
to as a “repeated measures” simulation. The second set of simulations represents an 
experiment where it is not possible to achieve multiple specimens from each donor 
and only one specimen per donor is included in the study.  In this second set of 
simulations, a design with 5 experimental groups and 3 specimens in each group 
requires 15 donors (1 specimen from each donor for a total of 15 specimens). This 
second type of simulation is referred to as a “general” simulation.  
Traditionally, statistical power is reported and used to determine the reliability 
of experimental results; however, more recent statistics literature has highlighted the 
limitations of expressing statistical power as a single number and recommends 
reporting a confidence interval along with the traditional statistical power [13, 14].  
For this reason, both statistical power (at α = 0.05) and the 95% confidence interval in 
the slope (B1) are reported for the simulations. Consistent with recent 
recommendations in the statistics community, a statistical power of 0.90 is considered 
to be acceptable for a study design [15]. 
 
3.2.1 Regression Fit Model 
Two sets of simulations were performed, one where 5 experimental groups and 
another where 9 experimental groups were used (Table 3). Simulations for both two 
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and three-dimensional measures of microdamage were performed for each study 
design. In simulations where there are an equal number of specimens per donor as 
experimental groups (the ‘repeated measures’ approach), the 95% confidence interval 
of B1 narrows and essential statistical power increases with an increase in the number 
of experimental groups (Figure 6). For example, when using two-dimensional 
measurement techniques with 9 donors, essential statistical power for an experiment 
with 5 groups (45 total specimens) is 0.8600 whereas for an experiment with 9 groups 
(81 total specimens) is 0.9558. When using three-dimensional measures, there is a 
reduction in the number of donors necessary to acquire sufficient convergence of the 
95% confidence interval and essential statistical power. For an experiment with 9 
groups, only 6 donors (54 total specimens, Table 3) are needed whereas for an 
experiment with 5 groups, only 7 donors (35 total specimens, Table 3) are needed.  
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Table of Experiment Designs Simulated with Results Determined by the Statistical Code 
Table 2: Each simulation was performed using two and three dimensional data. If the simulation was deemed ‘paired’, a specimen 
from each donor was placed in each group (i.e. number of groups = 4, 4 specimens per donor, one specimen per group). 
 
Experiment 
Type 
Simulation 
Type 
Number 
of Groups 
Mechanical Strain 
Applied to Each Group Measure 
Donors per 
Experiment 
Total Number 
of Specimens 
Specimens 
per Donor 
Regression 
Model 
Repeated 
Measures 9 
0%, 0.25% 0.5%, 0.75%, 
1.0%, 1.25% 1.5%, 
1.75%, 2.0%, 2.5% 
2D 8 72 9 
3D 6 54 9 
Regression 
Model 
Repeated 
Measures 5 
0%, 1.0%, 1.5%, 
 2.0%, 2.5% 
2D 11 55 5 
3D 7 35 5 
Regression 
Model General 9 
0%, 0.25% 0.5%, 0.75%, 
1.0%, 1.25% 1.5%, 
1.75%, 2.0%, 2.5% 
2D 54 54 1 
3D 36 36 1 
Regression 
Model General 5 
0%, 1.0%, 1.5%, 
 2.0%, 2.5% 
2D 45 45 1 
3D 30 30 1 
T-test Repeated Measures 2 0%, 1% 
2D 51 102 2 
3D 31 62 2 
T-test Repeated Measures 2 0%, 2.5% 
2D 12 24 2 
3D 8 16 2 
T-test General 2 0%, 1% 
2D 98 98 1 
3D 56 56 1 
T-test General 2 0%, 2.5% 
2D 22 22 1 
3D 14 14 1 
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95% Confidence Interval of B1 and Essential Statistical Power for Paired 
Regression Studies 
  
Figure 6: Simulation results of the repeated measures regression model are shown. 
The 95% confidence interval of B1 (left) and essential statistical power (right) are 
gradually affected by the addition of donors. For example, an experiment that utilizes 
two-dimensional measurement techniques with 5 experimental groups would require 
at least 11 donors with 5 specimens per donor thus 55 total specimens. 
 
In simulations where only one specimen per donor is used and specimens are 
randomly assigned experimental groups (the ‘general’ approach), increasing the 
number of experimental groups reduces the number of specimens per group required 
to achieve essential statistical power (Figure 7). As an example, when using two-
dimensional measures of microdamage, essential statistical power of 0.90 for a study 
with 5 experimental groups can be achieved using 9 specimens per group (54 total 
specimens, Table 3). When using three-dimensional measures of microdamage even 
fewer specimens are required. When three-dimensional measures of microdamage are 
used, essential statistical power of 0.90 can be achieved when using 6 specimens per 
group (24 total specimens, Table 3).  
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95% Confidence Interval of B1 and Essential Statistical Power for General 
Regression Studies 
  
Figure 7: Simulation results using the general regression model are shown. For a 
general regression only one specimen per donor is used and randomly assigned an 
experimental group. The 95% confidence interval of B1 (left) narrows and essential 
statistical power (right) increases as more specimens are added to each group. When 
there are a large number of experimental groups fewer specimens per group are 
necessary for the 95% confidence interval of B1 and statistical power to converge than 
when there are fewer experimental groups. For example, an experiment that utilizes 
two-dimensional measurement techniques with 5 experimental groups requires at least 
9 specimens per group or 45 donors, one specimen per donor. 
 
3.2.2 Analysis of T-Tests 
When only two experimental groups are included, the model is identical to a t-
test (Figure 2) [9]. The most common implementation of such a design in bone 
biomechanics is an experiment that involves a non-loaded control group and a loaded 
experiment group.  In the regression model the intercept of the line is the mean of the 
control group and the slope of the line is the size of the effect of treatment (in the 
current example, applied mechanical strain).  
For the repeated measures approach (there are two specimens per donor, one 
specimen in the control group and one in the experimental group), increases in effect 
  24 
size resulted in improved statistical power. If specimens are loaded to an apparent 
strain value just beyond yield (1.0% for human cancellous bone) and two-dimensional 
measures of microdamage are used, a large number of donors are needed to acquire a 
statistical power of 0.90 (Figure 8, Table 3). However, if the load magnitude is 
increased well beyond yield (apparent strain = 2.25%), the number donors of donors 
necessary to achieve essential statistical power using two-dimensional measurement 
techniques is reduced by 75% (Figure 8, Table 3).  Three-dimensional measurement 
techniques can be used to reduce the number of donors required for essential statistical 
power and 95% confidence intervals of B1 to a more manageable level (Figure 8, 
Table 3). 
95% Confidence Interval of B1 and Essential Statistical Power for Paired T-Test 
Studies 
  
 
Figure 8. The 95% confidence interval of B1 (left) and essential statistical power 
(right) are far less sensitive to the addition of more donors than the regression models. 
To detect small differences in microdamage (low applied strains), a large number of 
donors are necessary. For example, an experiment that utilizes two-dimensional 
measurement techniques with an applied strain of 1.0% (a typical biomechanics study) 
40 donors (80 total specimens) are required for convergence of the 95% confidence 
interval of B1. 
 
  25 
For a general t-test (only one specimen per donor randomly assigned to the 
control or experimental group), increases in effect size resulted in improved statistical 
power. Changing the measurement technique from two-dimensional to three-
dimensional drastically increased power and reduced the 95% confidence interval 
(Figure 9, Table 3). 
95% Confidence Interval of B1 and Essential Statistical Power for Paired 
T-Test Studies 
  
 
Figure 9. Experimental outcomes for a general t-test are shown. The general t-test 
shows very low statistical power and should only be used if large effect sizes are being 
detected or a large number of donors with extremely accurate and precise 
measurements are used. For small differences between groups (low applied strains 
~1.0%), a large number of specimens per group is required. For an experiment using 
two-dimensional measurement techniques with an applied strain of 1.0%, 40 
specimens per group (80 donors) are required for convergence of the 95% confidence 
interval of B1. 
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4.0 DISCUSSION 
The analysis suggests that when using two-dimensional stereology techniques 
very little benefit in measurement error is observed by examining more than 3 sections 
of 40 mm2 each (Figures 4 and 5). Three-dimensional microdamage measures can 
further reduce measurement error and is preferred when the technique is available. 
Increasing the number of experimental groups will reduce the number of specimens 
per group needed to detect meaningful trends between applied mechanical loading and 
amounts of microdamage (Figures 4 and 5).  
While each experiment is limited by the number of donors and complexity of 
specimen preparation, some ideal study designs based on this investigation are 
proposed.  The results from the analysis suggests that when measuring microdamage 
using two-dimensional sections based on the sampling guidelines reported near the 
beginning of the paper and the number of specimens per donor is not severely limited 
(i.e. beams of cortical bone from the femoral diaphysis, vertebral cancellous bone, 
etc.) an attractive repeated measures study design uses 11 donors and 5 experimental 
groups where each group has one specimen from each donor (i.e. 5 specimens from 
each donor). In cases where the number of specimens per donor is limited (i.e. 
cancellous bone cores from the proximal femur, biopsy specimens, etc.) and the 
number of donors is not as limited a study design using 45 donors separated into 5 
experimental groups using a general regression test (one specimen per donor randomly 
assigned to an experimental group) is recommended. Two experimental groups (t-test) 
are recommended only when large differences in microdamage are expected (for 
example when the applied strain approaches ultimate strain).  
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A major strength of the current study is that it generalizes previous models of 
sampling microdamage. The current model can be used for either cortical or 
cancellous bone, includes both crack density and diffuse damage measures, and 
incorporates both two-dimensional and three-dimensional approaches to examining 
microdamage. Although the implementation of this model in this thesis examines the 
relationship between applied loading (applied mechanical strain) and microdamage, 
the model design is general and can be applied to a study with any continuous and 
independent variable assigned as the “stimulus”.  
There are limitations to the analysis, however. First, the models assume that 
each microdamage event is independent and that each event is equally likely to occur 
throughout the region observed. Microdamage events may not be independent of each 
other, particularly when three-dimensional imaging of microdamage is used; however, 
the spatial relationships between sites of microscopic tissue damage are not well 
understood and would represent an additional unknown parameter in the statistical 
models.  
The most efficient study design is dependent on the goal of the study. If the 
goal of the study is to determine the effect of a stimulus, a t-test would be sufficient; 
however, either the difference between the control and experimental group or the 
number of specimens must be large.  Instead of determining if there is an effect of 
treatment; one may instead determine the relationship between the stimulus and 
response by increasing the number of experimental groups.  A reasonable number of 
specimens, if allocated appropriately, can accurately predict the relationship between 
the applied stimulus and resulting amounts of microdamage.  The measurement of 
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microdamage in bone is challenging, both from the subjective nature of identification 
of microdamage as well as from a sampling standpoint.  Appropriate study design, 
however, can reduce the variance in a study and provide better insights into the 
formation of microdamage in bone tissue. 
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APPENDIX 1 
Four software packages were created and are included in Appendix 2.  Each file may 
be copied into R (available for free on most operating systems at http://www.r-
project.org/). R or R Studio can be used to run any of the software packages included.  
To run the software, highlight the entire function within the file and ‘evaluate the 
selection’.  At the bottom of the function is an example case which then can be 
evaluated using the same process. Each parameter in the function can be altered due to 
specific experimental conditions.   
The following pages include definitions of each parameter used in each of the 
statistical modeling software programs. A table of values used for each simulation in 
the manuscript is included as well.  
  
  30 
Measurement Error Analysis 
Filename: MeasurementErrorCracks.r (To be used for analysis with crack density or 
other parameters that are measured as a ratio of a discrete variable over a continuous 
variable.) 
Title: Title of the simulated experiment.  
S.n: Number of specimens within the simulated experiment.  
M.n: Number of sections analyzed per specimen.  
FieldSize: Cross-sectional area analyzed per section. The value 1 was equivalent to a 
cross-sectional area of 42 mm2. Field Size is scaled based on the ratio of the desired 
cross-sectional area over 42.  
T.median: Population median of true crack density. This parameter is utilized when 
the behavior of the distribution is skewed.  
T.gmean: Population geometric mean of true crack density. This parameter is utilized 
when the measure is normally distributed. 
T.RS95: The 95% relative spread of the crack density. It is the ratio of 97.5% and 
2.5% quantiles. The combination of the median (T.median) and the RS95 (T.RS95) 
parameters describes the distribution of a parameter. 
T.CV: The coefficient of variance defined as the Standard Deviation/Mean of crack 
density. The combination of the mean (T.gmean) and coefficient of variance (T.CV) 
completely describe a normal distribution. 
BV.median: Median number of bone points counted using stereology techniques.  
BV.RS95: The 95% relative spread of bone points counted using stereology 
techniques. 
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EffectSize: The effect size calculated as the ratio between the experimental and 
control groups for a t-test: median1/median2 or mean1/mean2. For example, if the 
effect size was 1.3, this would be equivalent to detecting a difference of 30% between 
groups. 
Null: Null value of the effect size. A value of 1.0 suggests there is no difference 
between groups. 
Alpha: Probability of a Type I error. 
S.cost: The relative cost (dollars, time, etc.) of adding one more specimen to the 
analysis. Although not studied in the primary text, S.cost may be used to optimize 
effort by the observer (efficiency in measurement is an important factor of stereology). 
M.cost: The relative cost (dollars, time, etc.) of adding one more section per specimen 
to the analysis (Not used in the study in the primary text).  
PRINT: Check to either allow or suppress the printing of a summary of parameter 
inputs. TRUE allowed for inputs to be printed in the output window, FALSE did not 
allow for inputs to be printed in the output window.  
Seed: A random number chosen by the user to begin the simulation. The same results 
to a simulation would be reported every time if the same inputs (including the seed 
number) were submitted.  
Ntrials: Number of simulated experiments to perform.  
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Table of Simulation Parameters for the Microcrack Simulation Code 
Table 4: Each simulation was performed using the parameters described below. 
Relevant figures associated with the parameters are also specified. 
 
Parameter Name Parameter Value  Figures Associated 
with Parameter 
S.n 10  
M.n 1 - 200 Figure 5 
FieldSize 0.714 - 1.857 Figure 4 
T.median 0.003  
T.RS95 6.5  
BV.median 2000 (BV/TV = 35%) 
1143 (BV/TV = 20%) 
571 (BV/TV = 10%) 
Figure 4 and Figure 5 
(left) 
BV.RS95 1.9  
EffectSize 1.3  
Null 1  
Alpha 0.05  
TestType t-test  
S.cost 100  
M.cost 5  
PRINT TRUE  
Seed 1234955  
Ntrials 5000  
 
  
  33 
The MeasurementErrorDiffuse.r file has a number of the same variables as the 
MeasurementErrorCracks.r file. Below are only the definitions of the parameters that 
are unique to the MeasurementErrorDiffuse.r file. A table of all the parameters used in 
the MeasurementErrorDiffuse.r file is also below. 
 
Filename: MeasurementErrorDiffuse.r (To be used for analysis with diffuse damage 
or other parameters that are measured as a ratio of two continuous variables.) 
 
M.RS95: The 95% relative spread of the number of damage points counted in a given 
section using stereology techniques. Because diffuse damage is a ratio of two 
continuous variables, there is a spread value that is necessary to properly define a 
distribution of the measurement. 
M.CV: Coefficient of variation of the number of damage points counted using 
stereology techniques in a given section.  
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Table of Simulation Parameters for the Diffuse Damage Simulation Code 
Table 5: Each simulation was performed using the parameters described below. 
Relevant figures associated with the parameters are also specified. 
 
Parameter Name Parameter Value  Figures Associated 
with Parameter 
S.n 10  
M.n 1 - 200 Figure 5 (right) 
FieldSize 0.714 - 1.857 Not Shown 
T.median 0.003  
T.RS95 6.5  
M.RS95 4  
EffectSize 1.3  
Null 1  
Alpha 0.05  
TestType t-test  
S.cost 100  
M.cost 5  
PRINT TRUE  
Seed 1234955  
Ntrials 5000  
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Number and Distribution of Study Groups Analysis 
Filename: StudyDesignMultipleComparisons.r (To be used when there are an equal 
number of specimens as experimental groups per donor) 
Title: Title of the simulated experiment. 
AS.pts: Applied strain values for the experimental groups in the study. For example, 
the value ‘c(0, 0.5, 1.0)’ includes three experimental groups: One control with 0.0% 
applied compressive strain, one with 0.5% applied compressive strain, and one with 
1.0% applied compressive strain. For this software, four sets of AS.pts values were 
used to represent four different experiment designs. Two designs represent a 
regression analysis with multiple applied strain values (9 experimental groups or 5 
experimental groups). The other two designs represent a t-test with either a small or 
large difference between applied strain values.  
AS.ref: The arbitrary reference strain value to properly calculate B0 and B1. 
S.n: Number of donors in each simulated study. 
M.n: Number of times each specimen is analyzed. 
B0.gmean: The geometric mean value (which in this case is the same as median) of 
B0 over all donors. The combination of B0.gmean and B0.RS95 completely define the 
distribution of B0s for the whole population. 
B0.RS95: The 95% relative spread (RS) of B0 over all donors. 
B1.gmean: The geometric mean value (which in this case is the same as median) of 
B1 over all donors. The combination of B1.gmean and B1.RS95 completely define the 
distribution of B1s for the whole population of interest. 
B1.RS95: The 95% relative spread of B1 over all donors. 
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TotalNoise.RS95: The 95% relative spread of the total randomness of each damage 
volume measurement. This can be determined by plotting the data, determining the 
regression fit, and calculating the maximum and minimum distance from the 
regression line.  
PropMeasNoise: The proportion of the TotalNoise parameter due to measurement 
error. This was based off of the measurement error analysis program.  
ConfLevel: The confidence level desired for the analysis. 
B1.null: The null value at which we would like to compare our estimated B1 in order 
to calculate statistical power. B1.null = 1 would be representative of a typical 
statistical power analysis. To be more confident in our results, we use a larger null 
value B1.null = 5  
Print: Set to TRUE or FALSE to allow or not allow the printing of parameter data 
Plot: Set to TRUE or FALSE to allow or not allow a graphical plot of simulation 1 
 LogScaleDV.BV: Set to TRUE to plot damage volume on a log-scale, set to FALSE 
to plot damage volume on a regular scale 
NewWindow: Set to TRUE or FALSE to allow or not allow a new window for each 
plot to be generated. 
Seed: A random number chosen by the user to begin the simulation. The same values 
would be reported by the simulation every time the same inputs (including the seed 
number) were submitted.  
Ntrials: Number of simulated experiments to perform (5000) 
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Table of Simulation Parameters for the Multiple Comparisons Regression 
Simulation Code 
Table 6: Each simulation was performed using the parameters described below. 
Relevant figures associated with the parameters are also specified. 
 
Parameter Name Parameter Value  Figures Associated 
with Parameter 
AS.pts 
c(0, 0.5, 1.0, 1.25, 1.5, 1.75, 2.0, 2.5) 9 Groups  
c(0,1.0, 1.5, 2.0, 2.5) 5 Groups 
c(0, 1.0) 2 Groups, small effect size 
c(0, 2.5) 2 Groups, large effect size  
Figure 6 
Figure 6 
Figure 8 
Figure 8 
AS.ref 2  
S.n 2 -20  
M.n 1  
B0.gmean 0.02  
B0.RS95 3  
B1.gmean 11  
B1.RS95 2  
TotalNoise.RS95 13 (2D), 7.16 (3D)  
PropMeasNoise 0.35 (2D), 0.05 (3D)  
ConfLevel 0.95  
B1.null 5  
Print TRUE  
Plot TRUE  
LogScaleDV.BV TRUE  
NewWindow TRUE  
Seed 1234955  
Ntrials 5000  
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The StudyDesignGeneral.r file has a number of the same variables as the 
StudyDesignMultipleComparisons.r file. Below are only the definitions of the 
parameters that are unique to the StudyDesignGeneral.r file. A table of all the 
parameters used in the StudyDesignGeneral.r file is also below. 
 
Filename: StudyDesignGeneral.r (To be used when there only one specimen from 
each donor that is randomly assigned an experimental group)  
n: Number of specimens in each experimental group. For example, the value ‘c(2, 3, 
2)’ would mean that there are 2 specimens assigned to applied strain 1, 3 specimens 
assigned to applied strain 2, and 2 specimens assigned to applied strain 3. For all 
experim6ents reported here, the number of specimens in each experimental group was 
the same for each set of simulations (n ranges from 2 – 20) for example, n = c(18, 18, 
18, 18, 18, 18, 18, 18, 18) means that there are 9 experimental groups and each group 
has 18 specimens in the group. 
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Table of Simulation Parameters for the General Regression Simulation Code 
Table 7: Each simulation was performed using the parameters described below. 
Relevant figures associated with the parameters are also specified. 
 
Parameter Name Parameter Value  Figures Associated with 
Parameter 
Title "Description of Experiment"  
AS.pts 
c(0, 0.5, 1.0, 1.25, 1.5, 1.75, 2.0, 2.5) 9 Groups  
c(0,1.0, 1.5, 2.0, 2.5) 5 Groups 
c(0, 1.0) 2 Groups, small effect size 
c(0, 2.5) 2 Groups, large effect size  
Figure 7 
Figure 7 
Figure 9 
Figure 9 
AS.ref 2  
n 
c(2, 2, 2, 2, 2, 2, 2, 2) 9 Groups  
c(2, 2, 2, 2, 2) 5 Groups 
c(2, 2) 2 Groups, small effect size 
c(2, 2) 2 Groups, large effect size  
Figure 7 
Figure 7 
Figure 9 
Figure 9 
B0.gmean 0.02  
B0.RS95 3  
B1.gmean 11  
B1.RS95 2  
TotalNoise.RS95 13 (2D), 3.5 (3D)  
PropMeasNoise 0.35 (2D), 0.05 (3D)  
ConfLevel 0.95  
B1.null 5  
Print TRUE  
Plot TRUE  
LogScaleDV.BV TRUE  
NewWindow TRUE  
Seed 1234955  
Ntrials 5000  
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APPENDIX 2 
 
Code Written in R for Measurement Error Analysis 
MeasurementErrorCracks.r 
# BoneMeasSim.CracksPUBA 
# Uses simulation to examine the statistical properties of bone measurement data. 
# Ralph O'Brien, obrienralph@gmail.com 
# in colloboration with Christopher Hernandez and Katherine Ehlert 
# XX April 2011 
 
# Summary. 
#  S: specimen 
#  S.n: number of independent specimens per group 
 
#  M.type: type of measurement, 
#          e.g. microcracks per mm^2 field, taken to stem from Poisson process. 
#  M: one sample measurement such as observed number of cracks in field. 
#     M varies naturally within specimen (within specimen variation) 
#  M.n: number of measurements per specimen. Increasing M.n reduces measurement 
#       error, shortens confidence intervals, increases power. 
#  FieldSize: field size in units of measurement. Example: if unit is mm^2, 
#             and field is 2mm x 2mm = 4mm^2, then FieldSize = 4. 
#             Increasing FieldSize reduces measurement error, shortens confidence 
#             intervals, increases power.  
 
#  T: true value of M per unit of measurement, if the entire specimen was 
#     measured perfectly. T varies from specimen to specimen (between speciment 
variation) 
 
#  Distribution of T varies over specimens depending on type of 
#          measurement. 
#      <> For CracksPoisson(), T varies according to a logNormal 
#         distribution with paramaters 
#            T.median: the median number of cracks per unit measure   
#            T.RS95: the intra-95% relative spread, which is the ratio of 
#                       0.975 and 0.025 quantiles. See example. 
#         -or 
#            T.gmean: the population geometric mean; equivalent to pop. median 
#            T.CV: the coefficient of variation 
# 
#          Example. T.median = 0.10/mm^2 and T.RS95 = 3.0 defines 0.975 and 0.025 
#                   quantiles as 0.175 and 0.057. 
#          Verify: round(exp(c(log(.10) - log(3)/1.96, log(.10) + log(3)/1.96)),3)) 
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# 
#          Note: Using T.median and T.RS95 is generally an easier way to characterize 
#          the logNormal than is using the 'standard' parameterization based on 
#          T.gmean and T.CV. 
 
 
# Simulation results 
# ================== 
 
#  T.est: estimate of T for a specimen, based on all M.total measurements. 
#         This is the variable used in the actual study. 
 
#  E: error of measurement (T.est versus T) for a given specimen. 
#     For example, E = T.est/T is the relative difference of T.est vs. T. 
#     Such values will tend to be right skewed in distribution. 
# 
#  E.median: median of E over an infinite number of specimens. 
#            If the measure is median unbiased, then E.median = 1. 
#  E.RS95: intra-95% relative spread over infinite number of specimens, that is, 
#              the ratio of the 0.975 and 0.025 quantiles. 
#    Note that E.median and E.RS95 completely specify a logNormal distribution for E, 
#    just as the mean and coefficient of variation do. For E.median = 1 and 
#    E.RS95 = 1.2, the logNormal-based 0.025 and 0.975 quantiles for E = T.est/T 
#    are 0.911 and 1.097, indicating that 95% of the estimates for T are 
#    within 10% of the true values. Increasing M.total would decrease E.RS95 
#    and thus move the 0.025 and 0.975 quantiles for E = T.est/T closer to 
#    E.median = 1.0. 
#    R code: round(exp(c(log(1) - log(1.2)/1.96, log(1) + log(1.2)/1.96)),3) 
 
#  EffectSize: For studying a two-group comparison, this is the ratio 
#              T.median[1]/T.median[2], or T.gmean[1]/T.gmean[2] 
#              Example: EffectSize = 1.5 defines group 1's T.median (or T.gmean) to be 
#              1.5 times that of group 2. 
 
#  null:       Defines the test Ho: EffectSize = null 
#              For this problem, the usual null is 1.0. 
 
#  alpha:      Type I error rate. 1 - alpha is confidence level. 
 
#  dist.T.est: distribution of estimated true values over specimens. This relates 
#              to using T.est in studies. Specifically, the variability of T.est 
#              stems from both within specimen and between specimen 
#              variability. The former can reduced by increasing M.total. The 
#              latter is set by the types of specimens being studied. 
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#  S.cost: # Cost per specimen, scaled to be 100. 
#  M.cost: # Cost per measurement, scaled to be the % of cost of one specimen. 
#            In many cases, one will use S.total specimens to estimate, say, the 
#            geometric mean of T. If so, then the standard error of that estimate 
#            will be reduced by increasing either M.total or S.total. If the total 
#            cost is limited to C = M.cost*M.total + S.cost*S.total, what is the 
#            optimal choice of M.total and S.total that results in the lowest 
#            stanaard error?  
 
CracksPUBA = function( 
   title="a case with no title", 
   S.n,              # number of specimens 
   M.n,              # number of measurements per specimen 
   FieldSize=1,      # number of units of measure per field 
   T.median=NA,      # pop. median of true crack densities, T, for group 1, per unit 
measure 
   T.gmean=NA,       # pop. geometric mean of T, exp(mean(log(T))); equals pop. 
median T 
   T.RS95=NA,        # 95% relative spread of T; ratio of T(0.975) and T(0.025) 
quantiles 
   T.CV=NA,          # coeffcient of variation, SD/mean 
   BV.median,        # median BV 
   BV.RS95,          # 95% relative spread of T 
   EffectSize=1.0,   # effect size, median1/median2 or gmean1/gmean2 
   null=1.0,         # null value for effect size 
   alpha=0.05,       # Type I error rate; 1 - alpha is confidence level 
   TestType="t.test",# "t.test" = Welch t test on log(M) (var.equal = FALSE) 
                     # "GLM" Poisson regression, to be added 
   S.cost=100,       # cost per specimen 
   M.cost=NA,        # cost per measure 
   PRINT=TRUE,       # set to FALSE to suppress printing 
   seed=1234955,      # a seed to start simulations 
   Ntrials=5000)      # number of trials in simulations 
  { 
     
  if (PRINT) { 
    cat("\n\n",title,"\n\n") 
    print(data.frame(S.n, M.n,FieldSize),row.names=""); cat("\n") 
    print(data.frame(T.median,T.RS95,T.gmean,T.CV),row.names=""); cat("\n") 
    print(data.frame(EffectSize,null,alpha,TestType,row.names="")); cat("\n") 
    print(data.frame(S.cost,M.cost,row.names="")) 
    cat("\nTotal Cost:", S.cost*S.n + M.cost*M.n,"\n\n") 
    print(data.frame(PRINT,seed,Ntrials,row.names="")); cat("\n") 
  } 
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  set.seed(seed) 
  T <- rep(NA,Ntrials) 
  T.est <- rep(NA,Ntrials) 
  M <- rep(NA,S.n) 
  group <- c(rep(0,S.n), rep(1,S.n)) 
  EffSize <- c(rep(1,S.n), rep(1/EffectSize,S.n)) 
  estimate <- rep(NA,Ntrials) 
  CI.lo <- rep(NA,Ntrials) 
  CI.hi <- rep(NA,Ntrials) 
  BV <- rep(NA,Ntrials) 
 
  if (!is.na(T.median)) { 
    if (T.median <= 0) { 
      stop ("\n\nT.median must be positive.") 
    } 
    EffectType <- "T.median[1]:T.median[2]" 
    mean.logT <- log(T.median) 
  } else if (!is.na(T.gmean)) { 
      if (T.gmean <= 0) { 
        stop ("\n\nT.gmean must be positive.") 
      } 
      EffectType <- "T.gmean[1]:T.gmean[2]" 
      mean.logT <- log(T.gmean) 
    } else { 
        stop ("\n\nMust supply either T.median or T.gmean.") 
    } 
     
  if (!is.na(T.RS95)) { 
    if (T.RS95 <= 0) { 
      stop ("\n\nT.RS95 must be positive.") 
    } 
    SD.logT <- log(T.RS95)/(1.96*2) 
  } else if (!is.na(T.CV)) { 
      if (T.CV <= 0) { 
        stop ("\n\nT.CV must be positive.") 
      } 
      SD.logT <- sqrt(log(T.CV^2 + 1)) 
    } else { 
        stop ("\n\nMust supply either T.RS95 or T.CV.") 
    } 
     
  meanLnBV <- log(BV.median) 
  StdevLnBV <- log(BV.RS95)/(2*1.96) 
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  for (itrial in 1:Ntrials)  { 
    BV[itrial] <- round(exp(rnorm(1,meanLnBV,StdevLnBV))) 
    T[itrial] <- exp(rnorm(1,mean.logT,SD.logT)) 
    T.est[itrial] <- 
mean(rpois(M.n,T[itrial]*BV[itrial]*FieldSize))/(BV[itrial]*FieldSize) 
 
    for (S in 1:(2*S.n)) { 
      BV.S <- round(exp(rnorm(1,meanLnBV,StdevLnBV))) 
      T.S <- exp(rnorm(1,mean.logT,SD.logT))  # T for this S 
      M[S] <- mean(rpois(M.n,EffSize[S]*T.S*BV.S*FieldSize))/(BV.S*FieldSize) 
      if (M[S] == 0) { 
        cat("\n\nNote: A specimen was observed to have O total cracks over all 
measurements", 
            "\nThis was set to be 0.5 total cracks.\n") 
        M[S] <- (0.50/M.n)/(BV.S*FieldSize) 
      } 
    } 
 
    if (TestType == "t.test") { 
      tt <- t.test(log(M)~group, conf.level=1-alpha) 
      estimate[itrial] <- exp(tt$estimate[1])/exp(tt$estimate[2]) 
      CI.lo[itrial] <- exp(tt$conf.int[1]) 
      CI.hi[itrial] <- exp(tt$conf.int[2]) 
    } 
  } 
  E <- T.est/T 
  E.qvals <- quantile(E,c(0.025,0.500,0.975)) 
   
  SD.logT.est <- sd(T.est) 
  SE.logT.est <- SD.logT.est/sqrt(S.n) 
 
  CLimsRatio <- CI.hi/CI.lo 
  CLims.qvals <- quantile(CLimsRatio,c(0.025,0.500,0.975)) 
  power <- sum((CI.lo > null) + (CI.hi < null) > 0)/Ntrials 
   
  if (PRINT) { 
    cat("\n\nDistribution of E = estimate:actual") 
    cat  ("\n===================================") 
    cat("\nMedian:", round(E.qvals[2],3)) 
    cat("\n0.025 & 0.975 quantiles:", round(E.qvals[1],2), round(E.qvals[3],2)) 
    cat("\n95% relative spread:", round(E.qvals[3]/E.qvals[1],2),"\n") 
 
    cat("\nProperties of", round(1-alpha,3), "confidence interval for", EffectType) 
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    cat  
("\n===========================================================
=======") 
    cat("\nMedian lower and upper limits:",round(median(CI.lo),2), 
round(median(CI.hi),2)) 
    cat("\nMedian ratio upper:lower limits:",round(median(CI.hi/CI.lo),2)) 
    cat("\n\nProportion not containing null =", null,":", round(power,3)) 
    cat ("\n(This is the statistical power of this case.)\n") 
  } 
# results <= list 
# invisible(qvals) 
} 
MeasurementErrorDiffuse.r 
# MeasurementErrorCracks.r 
# Uses simulation to examine the statistical properties of bone measurement data. 
# Ralph O'Brien, obrienralph@gmail.com 
# in collaboration with Christopher Hernandez and Katherine Ehlert 
# XX April 2011 
 
# Summary. 
#  S: specimen 
#  S.n: number of independent specimens per group 
 
#  M.type: type of measurement, 
#          e.g. microcracks per mm^2 field, taken to stem from Poisson process. 
#  M: one sample measurement such as observed number of cracks in field. 
#     M varies naturally within specimen (within specimen variation) 
#  M.n: number of measurements per specimen. Increasing M.n reduces measurement 
#       error, shortens confidence intervals, increases power. 
#  FieldSize: field size in units of measurement. Example: if unit is mm^2, 
#             and field is 2mm x 2mm = 4mm^2, then FieldSize = 4. 
#             Increasing FieldSize reduces measurement error, shortens confidence 
#             intervals, increases power.  
 
#  T: true value of M per unit of measurement, if the entire specimen was 
#     measured perfectly. T varies from specimen to specimen (between speciment 
variation) 
 
#  Distribution of T varies over specimens depending on type of 
#          measurement. 
#      <> For CracksPoisson(), T varies according to a logNormal 
#         distribution with paramaters 
#            T.median: the median number of cracks per unit measure   
#            T.RS95: the intra-95% relative spread, which is the ratio of 
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#                       0.975 and 0.025 quantiles. See example. 
#         -or 
#            T.gmean: the population geometric mean; equivalent to pop. median 
#            T.CV: the coefficient of variation 
# 
#          Ezxample. T.median = 0.10/mm^2 and T.RS95 = 3.0 defines 0.975 and 0.025 
#                   quantiles as 0.175 and 0.057. 
#          Verify: round(exp(c(log(.10) - log(3)/1.96, log(.10) + log(3)/1.96)),3)) 
# 
#          Note: Using T.median and T.RS95 is generally an easier way to characterize 
#          the logNormal than is using the 'standard' parameterization based on 
#          T.gmean and T.CV. 
 
 
# Simulation results 
# ================== 
 
#  T.est: estimate of T for a specimen, based on all M.total measurements. 
#         This is the variable used in the actual study. 
 
#  E: error of measurement (T.est versus T) for a given specimen. 
#     For example, E = T.est/T is the relative difference of T.est vs. T. 
#     Such values will tend to be right skewed in distribution. 
# 
#  E.median: median of E over an infinite number of specimens. 
#            If the measure is median unbiased, then E.median = 1. 
#  E.RS95: intra-95% relative spread over infinite number of specimens, that is, 
#              the ratio of the 0.975 and 0.025 quantiles. 
#    Note that E.median and E.RS95 completely specify a logNormal distribution for E, 
#    just as the mean and coefficient of variation do. For E.median = 1 and 
#    E.RS95 = 1.2, the logNormal-based 0.025 and 0.975 quantiles for E = T.est/T 
#    are 0.911 and 1.097, indicating that 95% of the estimates for T are 
#    within 10% of the true values. Increasing M.total would decrease E.RS95 
#    and thus move the 0.025 and 0.975 quantiles for E = T.est/T closer to 
#    E.median = 1.0. 
#    R code: round(exp(c(log(1) - log(1.2)/1.96, log(1) + log(1.2)/1.96)),3) 
 
#  EffectSize: For studying a two-group comparison, this is the ratio 
#              T.median[1]/T.median[2], or T.gmean[1]/T.gmean[2] 
#              Example: EffectSize = 1.5 defines group 1's T.median (or T.gmean) to be 
#              1.5 times that of group 2. 
 
#  null:       Defines the test Ho: EffectSize = null 
#              For this problem, the usual null is 1.0. 
 
  47 
#  alpha:      Type I error rate. 1 - alpha is confidence level. 
 
#  S.cost: # Cost per specimen, scaled to be 100. 
#  M.cost: # Cost per measurement, scaled to be the % of cost of one specimen. 
#            In many cases, one will use S.total specimens to estimate, say, the 
#            geometric mean of T. If so, then the standard error of that estimate 
#            will be reduced by increasing either M.total or S.total. If the total 
#            cost is limited to C = M.cost*M.total + S.cost*S.total, what is the 
#            optimal choice of M.total and S.total that results in the lowest 
#            stanaard error?  
 
DV_BV = function( 
   title="a case with no title", 
   S.n,              # number of specimens 
   M.n,              # number of measurements per specimen 
   FieldSize=1,      # number of units of measure per field 
   T.median=NA,      # pop. median of DV/BV, percent of bone with damage over 
entire specimen 
   T.gmean=NA,       # pop. geometric mean of T, exp(mean(log(T))); equals pop. 
median T 
   T.RS95=NA,        # 95% relative spread of T; ratio of T(0.975) and T(0.025) 
quantiles 
   T.CV=NA,          # coeffcient of between-specimen variation, SD/mean 
   M.RS95=NA,        # 95% relative spread of M within specimens 
                     # M.RS95 is restricted to be <70.1% of T.RS95 
                     # Default: M.RS95 = T.RS95/2 (50%) 
   M.CV=NA,          # coeffcient of within-specimen variation 
                     # M.CV is restricted to be <70.1% of T.CV 
   EffectSize=1.0,   # effect size, median1/median2 or gmean1/gmean2 
   null=1.0,         # null value for effect size 
   alpha=0.05,       # Type I error rate; 1 - alpha is confidence level 
   TestType="t.test",# "t.test" = Welch t test on log(M) (var.equal = FALSE) 
   S.cost=100,       # cost per specimen 
   M.cost=NA,        # cost per measure 
   PRINT=TRUE,       # set to FALSE to suppress printing 
   seed=1234955,     # a seed to start simulations 
   Ntrials=5000)     # number of trials in simulations 
  { 
     
  if (PRINT) { 
    cat("\n\n",title,"\n\n") 
    print(data.frame(S.n, M.n,FieldSize),row.names=""); cat("\n") 
    print(data.frame(T.median,T.RS95,T.gmean,T.CV),row.names=""); cat("\n") 
    print(data.frame(EffectSize,null,alpha,TestType,row.names="")); cat("\n") 
    print(data.frame(S.cost,M.cost,row.names="")) 
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    cat("\nTotal Cost:", S.cost*S.n + M.cost*M.n,"\n\n") 
    print(data.frame(PRINT,seed,Ntrials,row.names="")); cat("\n") 
  } 
   
  set.seed(seed) 
  T <- rep(NA,Ntrials) 
  T.est <- rep(NA,Ntrials) 
  M <- rep(NA,S.n) 
  group <- c(rep(0,S.n), rep(1,S.n)) 
  EffSize <- c(rep(1,S.n), rep(1/EffectSize,S.n)) 
  estimate <- rep(NA,Ntrials) 
  CI.lo <- rep(NA,Ntrials) 
  CI.hi <- rep(NA,Ntrials) 
 
  if (!is.na(T.median)) { 
    if (T.median <= 0) { 
      stop ("\n\nT.median must be positive.") 
    } 
    EffectType <- "T.median[1]:T.median[2]" 
    mean.logT <- log(T.median) 
  } else if (!is.na(T.gmean)) { 
      if (T.gmean <= 0) { 
        stop ("\n\nT.gmean must be positive.") 
      } 
      EffectType <- "T.gmean[1]:T.gmean[2]" 
      mean.logT <- log(T.gmean) 
    } else { 
        stop ("\n\nMust supply either T.median or T.gmean.") 
    } 
     
  if (!is.na(T.RS95)) { 
    if (T.RS95 <= 0) { 
      stop ("\n\nT.RS95 must be positive.") 
    }   
    SD.logT <- log(T.RS95)/(1.96*2) 
  } else if (!is.na(T.CV)) { 
      if (T.CV <= 0) { 
        stop ("\n\nT.CV must be positive.") 
      } 
      SD.logT <- sqrt(log(T.CV^2 + 1)) 
    } else { 
        stop ("\n\nMust supply either T.RS95 or T.CV.") 
    } 
     
  if ((is.na(M.RS95)) & (is.na(M.CV))) { 
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    M.RS95 -> exp(2*1.96*SD.logT)/2 
    if (PRINT) { 
      cat ("\n\nNote: M.RS95 has been set to 50% of S.RS95.") 
    } 
  } 
   
  if (!is.na(M.RS95)) { 
    if (M.RS95 <= 0) { 
      stop ("\n\nM.RS95 must be positive.") 
    } 
    if (M.RS95 > .70*exp(2*1.96*SD.logT)) { 
      stop ("\n\nM.RS95 must not exceed 70% of S.RS95.") 
    } 
    SD.logM <- log(M.RS95)/(1.96*2) 
  } else { 
      if (M.CV <= 0) { 
        stop ("\n\nM.CV must be positive.") 
      } 
    if (M.CV > .70*sqrt(exp(SD.logT))) { 
      stop ("\n\nM.CV must not exceed 70% of S.CV.") 
    } 
      SD.logM <- sqrt(log(M.CV^2 + 1)) 
    } 
       
  for (itrial in 1:Ntrials)  { 
    T[itrial] <- exp(rnorm(1,mean.logT,SD.logT)) 
    T.est[itrial] <- exp(mean(rnorm(M.n,log(T[itrial]),SD.logM))) # gmean of M.n 
measurements 
 
    for (S in 1:(2*S.n)) { 
      T.S <- exp(rnorm(1,mean.logT,SD.logT))  # T for this S 
      M[S] <- exp(mean(rnorm(M.n,log(EffSize[S]*T.S),SD.logM))) # gmean of M.n 
measurements 
    } 
 
    if (TestType == "t.test") { 
      tt <- t.test(log(M)~group, conf.level=1-alpha) 
      estimate[itrial] <- exp(tt$estimate[1])/exp(tt$estimate[2]) 
      CI.lo[itrial] <- exp(tt$conf.int[1]) 
      CI.hi[itrial] <- exp(tt$conf.int[2]) 
    } 
  } 
  E <- T.est/T 
  E.qvals <- quantile(E,c(0.025,0.500,0.975)) 
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  SD.logT.est <- sd(T.est) 
  SE.logT.est <- SD.logT.est/sqrt(S.n) 
 
  CLimsRatio <- CI.hi/CI.lo 
  CLims.qvals <- quantile(CLimsRatio,c(0.025,0.500,0.975)) 
  power <- sum((CI.lo > null) + (CI.hi < null) > 0)/Ntrials 
   
  if (PRINT) { 
    cat("\n\nDistribution of E = estimate:actual") 
    cat  ("\n===================================") 
    cat("\nMedian:", round(E.qvals[2],3)) 
    cat("\n0.025 & 0.975 quantiles:", round(E.qvals[1],2), round(E.qvals[3],2)) 
    cat("\n95% relative spread:", round(E.qvals[3]/E.qvals[1],2),"\n") 
 
    cat("\nProperties of", round(1-alpha,3), "confidence interval for", EffectType) 
    cat  
("\n===========================================================
=======") 
    cat("\nMedian lower and upper limits:",round(median(CI.lo),2), 
round(median(CI.hi),2)) 
    cat("\nMedian ratio upper:lower limits:",round(median(CI.hi/CI.lo),2)) 
    cat("\n\nProportion not containing null =", null,":", round(power,3)) 
    cat ("\n(This is the statistical power of this case.)\n") 
  } 
# results <= list 
# invisible(qvals) 
} 
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Code Written in R for Number and Distribution of Study Groups Analysis 
StudyDesignPaired.r 
# BoneMeasSimDV_BVcurve______.r 
# Uses simulation to examine the statistical properties of bone measurement data. 
# Ralph O'Brien, obrienralph@gmail.com 
# in collaboration with Christopher Hernandez and Katherine Ehlert 
# 2 May 2011 
 
# Background. 
# Figure 4 in Tang and Vashishth (2007) plots results for their study of a single 
specimen, 
# (S.n = 1), which measured and fit Damaged Bone Fraction (DV/BV, here DV.BV) to 
# % Apparent Strain (AS) at 9 design points: 
#     AS.pts <- c(0, 0.5, 0.75, 1.00, 1.25, 1.50, 1.75, 2.00, 2.25) 
# It appears that only one measurement (M.n = 1) was taken at each design point. 
# The multiplicative exponential model fit in that study was 
#    [M1]  DV.BV ~ 0.02 * exp(1.2*AS) 
# or, equivalently, the log-linear model 
#    [L1]  log(DV.BV) ~ log(0.02) + 1.2*AS 
 
# Aim. 
# This program performs simualations that generalize this type of study by generating 
# and analyzing data that conform to the model 
#    [M2]  DV.BV ~ B0 * B1^(AS/AS.ref) 
# where: 
#        B0 = gmean(AS=0), the geometric mean (here, same as median) of DV/BV 
when 
#             % Apparent Strain = 0; 
#        B1 = gmean(AS.ref)/gmean(AS=0), the fold change in DV/BV when 
#             going from AS = 0 to some reference point for AS, AS.ref > 0. 
# 
# The log-linear model is 
#     [L2]  log(DV.BV) ~ log(B0) + (AS/AS.ref) * log(B1) 
 
# Note. It is straightforward to show that M2 amd M1 are equivalent models, just 
expressed 
# in a different ways: 
#     [M1] DV.BV ~ B0 * exp(B1'*AS) = B0 * exp((ref.AS*B1')*(AS/AS.ref)) = 
#                  B0 + B1^(AS/AS.ref), 
# where B1 = exp(ref.AS*B1'). The parameters in model [M2] are simpler to use. 
 
# For example, take the Tang and Vashishth (2007) plot. At AS = 0 and ref.AS = 2, 
# DV/BV values are about 0.02 and 0.22, so the model is roughly  
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#            DV.BV ~ 0.02 * (0.22/0.02)*(AS/2) = 0.02 * 11^(AS/2), 
# saying that DV/BV is 0.02 at 0% Apparent Strain, 0.02*11^(0.50) = 0.02*sqrt(11) = 
# 0.066 at AS = 1%, and 0.02*11 = 0.22 at AS = 2%. 
# 
# Note. This is nearly identical to the fit shown in T&V's Figure 4: 
#      DV.BV = 0.02 * exp(1.2*AS) = 0.02 * exp(2.4)^(AS/2) = 0.02 * 11.02*(AS/2). 
#  
# Specifically, this function allows for varying the 
#   (1) number and position of the AS design points. Note. Using two design points, 
AS=0 vs AS=ref.AS, 
# sets up a two-group problem, which is handled here by a simple t-test whether the 
geometric mean of 
# [DV.BV(AS=ref.AS)]/[DV.BV(AS=0)] = 1.0. See example. 
#   (2) values for gmeans at each design point. 
#   (3) relative variation of "true" values for B0 and B1 from specimen to specimen. 
#   (4) relative variation of observed values of DV.BV from measurement to 
measurement within 
#       each subject. 
#   (5) number of specimens; each specimen measured M.n times at each design point. 
#   (6) number of measurements per specimen per design point. 
# 
# All relevant parameter values are modifiable in the function call; see examples.   
 
 
# Summary. 
# ======== 
#     AS.pts: Apparent Strength design points, such as 
#             AS.pts = c(0, 0.5, 0.75, 1.00, 1.25 1.50, 1.75, 2.00, 2.25) 
 
#     ref.AS: reference design point, single value, such as ref.AS = 2. 
 
#        S.n: number of independent specimens. Each specimen is measured at each 
#              design point. 
 
#        M.n: number of measurements at each design point. 
 
#     B0.gmean: geometric mean value (same as median) of B0 over specimens. As 
above, 
#               B0 is the true value of DV/BV when % Apparent Strain = 0. B0 varies 
#               from specimen to specimen. Assumed to be logNormal in shape. 
 
#      B0.RS95: the 95% relative spread of B0 over specimens. For example, 
#               B0.RS95 = 3 indicates that the top versus the bottom of the middle 95% 
#               of the B0 logNormal distribution has a ratio of 3.0. 
#               Note: B0 is not varying within specimen; such randomness has been 
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#               dumped into the noise component. 
# 
#     B1.gmean: geometric mean value (same as median) of B1 over specimens. As 
above, 
#               B1 is the median(ref.AS)/median(AS=0), the fold change in DV/BV when 
#               going from AS = 0 to some reference point for AS, ref.AS > 0. B1 varies 
#               from specimen to specimen. Assumed to be logNormal in shape. 
 
#      B1.RS95: the 95% relative spread of B1 over specimens. For example, 
#               B0.RS95 = 2 indicates that the top versus the bottom of the middle 95% 
#               of the B1 logNormal distribution has a ratio of 2.0. 
#               Note: B1 is not varying within specimen; such randomness has been 
#               dumped into the noise component. 
 
# TotalNoise.RS95: 
#               the 95% relative spread of the total randomness of each DV/BV 
#               measurement. This is due to variation within the specimen 
#               and measurement error. 
# 
# PropMeasNoise: 
#              proportion of TotalNoise due to measurement error 
# 
#    ConfLevel: Sets level of confidence intervals (e.g. 0.95). 
# 
#      B1.null: sets null for testing B1. The usual value is 1.0. "Rejecting" 
#               this says there is some relationship between AS and DV/BV. So what? 
 
 
# Simulation results, per trial 
# ============================= 
 
#   B1.est: geometric mean of B1 estimated over the specimens. 
 
#    B1.lo: lower 95% confidence limit for B1. 
#    B1.hi: upper 95% confidence limit for B1. 
# 
#  p.value: one-sided p.value for testing 
#             Ho: B1.gmean = B1.null 
#             Ha: B1.gmean > B1.null 
 
 
DV.BVcurve = function( 
   title="a case with no title", 
   AS.pts,            # design points for Apparent Strain, 
   AS.ref,            # reference design point for Apparent Strain, 
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   S.n,               # number of specimens 
   M.n,               # number of measurements per specimen at each design point 
   B0.gmean,          # geometric mean value (same as median) of B0 over specimens. 
   B0.RS95,           # the 95% relative spread (RS) of B0 over specimens. 
   B1.gmean,          # geometric mean value (same as median) of B1 over specimens. 
   B1.RS95,           # the 95% RS of B1 over specimens. 
   TotalNoise.RS95,   # the 95% RS of the total randomness of each DV/BV 
measurement. 
   PropMeasNoise=0.3, # proportion of TotalNoise due to measurement error 
   ConfLevel=0.95,    # level of confidence interval 
   B1.null,           # sets null for testing B1 
   Print=TRUE,        # set to FALSE to suppress printing 
   Plot=TRUE,         # set to FALSE to suppress plotting of Trial 1 data 
   LogScaleDV.BV=F,   # set to TRUE to log scale DV/BV axis 
   NewWindow=TRUE,    # set to FALSE to re-use the same plot window 
   seed=1234955,      # a seed to start simulations 
   Ntrials=1000)      # number of trials in simulations 
  { 
     
  if (Print) { 
    cat("\n\n",title,"\n") 
    cat("\nDesign Points:", AS.pts) 
    cat("\nRefefence Point:", AS.ref, "\n") 
    print(data.frame(S.n, M.n),row.names=""); cat("\n") 
    print(data.frame(B0.gmean,B0.RS95,B1.gmean,B1.RS95),row.names="") 
    cat("\n") 
    print(data.frame(TotalNoise.RS95, PropMeasNoise), row.names="") 
    cat("\n")     
    print(data.frame(ConfLevel,B1.null,row.names="")); cat("\n") 
    print(data.frame(Print,seed,Ntrials,row.names="")); cat("\n") 
    print(data.frame(Plot,LogScaleDV.BV,NewWindow,row.names="")); cat("\n") 
     
  } 
   
  set.seed(seed) 
  B1.est <- B1.lo <- B1.hi <- p.value <- CIspan<- rep(NA,Ntrials) 
  K <- length(AS.pts) 
     
  if (min(c(B0.gmean, B1.gmean)) <= 0) { 
    stop ("B0.gmean and B1.gmean must be positive.") 
    } 
   
  if (min(c(B0.RS95, B1.RS95)) <= 1) { 
    stop ("B0.RS95 and B1.RS95 must exceed 1.0.") 
  } 
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# Note: model assumes independence between B0 and B1. This can be changed. 
  mu.logB0 <- log(B0.gmean) 
  mu.logB1 <- log(B1.gmean) 
  SD.logB0 <- log(B0.RS95)/(1.96*2) 
  SD.logB1 <- log(B1.RS95)/(1.96*2) 
  SD.logTNoise <- log(TotalNoise.RS95)/(1.96*2) 
   
# Note: model assumes independence among noise values for all measures between 
# design pts. This can be changed. But assumes that measurements within design 
points are 
# correlated such that PropMeasNoise of the total noise variance (not SD) is 
measurement 
# error within design points. Probably impossible to know in any planning process. 
  SDnoise.meas <- sqrt((SD.logTNoise^2)*PropMeasNoise) 
  SDnoise.other <- sqrt((SD.logTNoise^2)*(1-PropMeasNoise)) 
 
  DV.BV <- matrix(rep(NA, S.n*M.n*K), nrow=S.n*M.n) 
  colnames(DV.BV) <- paste("DV.BV", 1:K, sep="") 
  donor=rep(1:S.n, each=M.n) 
  m=rep(1:M.n, times=S.n) 
       
  for (iTrial in 1:Ntrials)  { 
    logB1.s <- rep(NA, S.n) 
     
    ii <- 0 
    for (s in 1:S.n) { 
      logDV.BV <- X.AS <- rep(NA, K*M.n) 
 
      logB0 <- rnorm(1, mu.logB0, SD.logB0) 
      logB1 <- rnorm(1, mu.logB1, SD.logB1) 
       
      i <- 0 
      for (k in 1:K) { 
        AS <- AS.pts[k] 
        tempDV.BV <- logB0 + (AS/AS.ref)*logB1 + rnorm(1,0,SDnoise.other) 
        for (m in 1:M.n) { 
          i <- i + 1 
          X.AS[i] <- AS 
          logDV.BV[i] <- tempDV.BV + rnorm(1,0,SDnoise.meas) 
          DV.BV[ii+m,k] <- exp(logDV.BV[i]) 
        } 
      } 
      ii <- ii + M.n 
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      if (Print & (iTrial==1) & (s==1)) { 
        cat("\n\nFirst specimen in first trial\n") 
        print (data.frame(AS=X.AS, DV.BV=round(exp(logDV.BV),3))) 
      } 
       
      X.ASvRef <- X.AS/AS.ref 
      logB1.s[s] <- lm(logDV.BV ~ X.ASvRef)$coefficients[2]     
    } 
 
    if (Plot & (iTrial==1)) {  # make spaghetti plot of Trial 1 data 
     plottitle <- paste("Data for Trial #1\nDonors:", S.n, "    Measurements per Donor:", 
M.n) 
     if (NewWindow) { 
        try(windows(width=6, height=5), silent=T) 
        try(quartz(width=6, height=5), silent=T) 
      } 
      
Ymin <- 0; LogScaling = ""; Ylabel <- "Damaged Volume Fraction (DV/BV)" 
if (LogScaleDV.BV) { 
LogScaling = "y" 
DV.BV[DV.BV[,] < 0.001] = 0.001 
Ymin <- min(0.001, min(DV.BV)) 
Ylabel <- "Damaged Volume Fraction (DV/BV; log-scaled)" 
} 
Ymax <- max(0.8, max(DV.BV)) 
plot(DV.BV[1,] ~ AS.pts, 
ylim= c(Ymin, Ymax), 
xlim= c(0, 2.5), 
ylab=Ylabel, 
xlab = "Apparent Strain (%)", 
type="l", lwd=0.8, col=1, 
xaxt="n", 
log=LogScaling, 
las=1, 
cex.axis= 0.75, cex.lab=0.85, 
main=plottitle) 
axis(1, at=c(0, 0.5, 1, 1.5, 2, 2.5), cex.axis=0.75) 
         for (i in 2:length(DV.BV[,1])) { 
          lines(DV.BV[i,] ~ AS.pts, col=donor[i], lwd=0.8) 
         } 
    } 
     
    null <- log(B1.null) 
    t <- t.test(logB1.s, mu=null, conf.level=ConfLevel) 
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    names(t) 
    B1.est[iTrial] <- exp(t$estimate) 
    B1.lo[iTrial] <- exp((t$conf.int[1])) 
    B1.hi[iTrial] <- exp((t$conf.int[2])) 
    CIspan[iTrial] <- B1.hi[iTrial]/B1.lo[iTrial] 
    if (B1.est[iTrial] > 1) { 
      p.value[iTrial] <- t$p.value/2 
    } 
      else { 
       p.value[iTrial] <- 1 - t$p.value/2 
    } 
     
  } 
     
  power <- sum((p.value < 0.05) > 0)/Ntrials 
  p.qvals <- quantile(p.value,c(0.25,0.500,0.75,0.80,power)) 
  B1.qvals <- quantile(B1.est,c(0.025,0.975)) 
 
  if (Print) { 
  cat("\n\nResults for first 10 trials\n") 
  first10 <- data.frame(B1.est=round(B1.est,2), 
                        B1.lo=round(B1.lo,2), 
                        B1.hi=round(B1.hi,2), 
                        p.value=p.value, 
                        CIspan=round(CIspan,2))[1:10,] 
  print(first10) 
  } 
   
# Preliminary code to analyze the simulation study 
{ 
  cat("\n\nSummary of B1 estimates; true =", B1.gmean, "\n") 
  print(round(exp(summary(log(B1.est))),2)) 
  cat("\n\n95% quantile range of the B1 estimates\n") 
  print(round(B1.qvals,2)) 
  cat("\n\nSummary of B1 lower confidence limits\n") 
  print(round(exp(summary(log(B1.lo))),2)) 
  cat("\n\nSummary of B1 upper confidence limits\n") 
  print(round(exp(summary(log(B1.hi))),2)) 
  cat("\n\nSummary of CI span = B1.hi/B1.lo\n") 
  print(round(exp(summary(log(CIspan))),2)) 
  cat("\n\nSummary of B1 p.values; one-sided test of B1 > ", B1.null, "\n") 
  print(summary(p.value,3)) 
  cat("\n Quantiles\n 0.25   0.50   0.75   0.80   power\n", round(p.qvals[1],4), 
round(p.qvals[2],4), round(p.qvals[3],4), round(p.qvals[4],4), round(p.qvals[5],4)) 
  cat("\n\n Proportion with a p.value < 0.05 :", round(power,4)) 
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  cat("\n(This should be the statistical power of this case.)\n") 
  } 
   
} # end DV.BVcurve ()  
 
StudyDesignGeneral.r 
# OneSpecPerDonorDV_BVcurve______.r 
# Uses simulation to examine the statistical properties of bone measurement data study 
# in which only one specimen is used per donor. 
# Ralph O'Brien, obrienralph@gmail.com 
# in collaboration with Christopher Hernandez and Katherine Ehlert 
# 7 Sept 2012 
 
# Background. 
# Figure 4 in Tang and Vashishth (2007) plots results for their study of a single 
specimen, 
# (S.n = 1), which measured and fit Damaged Bone Fraction (DV/BV, here DV.BV) to 
# % Apparent Strain (AS) at 9 design points: 
#     AS.pts <- c(0, 0.5, 0.75, 1.00, 1.25, 1.50, 1.75, 2.00, 2.25) 
# It appears that only one measurement (M.n = 1) was taken at each design point. 
# The multiplicative exponential model fit in that study was 
#    [M1]  DV.BV ~ 0.02 * exp(1.2*AS) 
# or, equivalently, the log-linear model 
#    [L1]  log(DV.BV) ~ log(0.02) + 1.2*AS 
 
# Aim. 
# This program performs simulations that alter this type of study in that only one 
specimen 
# is used from each donor. 
# We use the statistical model 
#    [M2]  DV.BV ~ B0 * B1^(AS/AS.ref) 
# where: 
#        B0 = gmean(AS=0), the geometric mean (here, same as median) of DV/BV 
when 
#             % Apparent Strain = 0; 
#        B1 = gmean(AS.ref)/gmean(AS=0), the fold change in DV/BV when 
#             going from AS = 0 to some reference point for AS, AS.ref > 0. 
# 
# The log-linear model is 
#     [L2]  log(DV.BV) ~ log(B0) + (AS/AS.ref) * log(B1) 
 
# Note. It is straightforward to show that M2 amd M1 are equivalent models, just 
expressed 
# in a different ways: 
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#     [M1] DV.BV ~ B0 * exp(B1'*AS) = B0 * exp((ref.AS*B1')*(AS/AS.ref)) = 
#                  B0 + B1^(AS/AS.ref), 
# where B1 = exp(ref.AS*B1'). The parameters in model [M2] are simpler to use. 
# 
 
# For example, take the Tang and Vashishth (2007) plot. At AS = 0 and ref.AS = 2, 
# DV/BV values are about 0.02 and 0.22, so the model is roughly  
#            DV.BV ~ 0.02 * (0.22/0.02)*(AS/2) = 0.02 * 11^(AS/2), 
# saying that DV/BV is 0.02 at 0% Apparent Strain, 0.02*11^(0.50) = 0.02*sqrt(11) = 
# 0.066 at AS = 1%, and 0.02*11 = 0.22 at AS = 2%. 
# 
# Note. This is nearly identical to the fit shown in T&V's Figure 4: 
#      DV.BV = 0.02 * exp(1.2*AS) = 0.02 * exp(2.4)^(AS/2) = 0.02 * 11.02*(AS/2). 
#  
# Specifically, this function allows for varying the 
#   (1) number and position of the AS design points. Note. Using two design points, 
AS=0 vs AS=ref.AS, 
# sets up a two-group problem, which is handled here by a simple t-test whether the 
geometric mean of 
# [DV.BV(AS=ref.AS)]/[DV.BV(AS=0)] = 1.0. See example. 
#   (2) sample size at each design point. 
#   (3) values for B0 and B1. 
#   (3) amount of totalnoise, expressed as 95% relative spread 
# 
# All relevant parameter values are modifiable in the function call; see examples.   
 
 
# Summary. 
# ======== 
#     AS.pts: Apparent Strength design points, such as 
#             AS.pts = c(0, 0.5, 0.75, 1.00, 1.25 1.50, 1.75, 2.00, 2.25) 
 
#     ref.AS: reference design point, single value, such as ref.AS = 2. 
 
#         n: number of independent donors used at the given design points. 
 
#         B0: geometric mean of DV/BV when % Apparent Strain = 0, gmean(AS=0). 
# 
#         B1: gmean(AS=ref.AS)/gmean(AS=0), the fold change in DV/BV when 
#               going from AS = 0 to some reference point for AS, ref.AS > 0. 
 
# TotalNoise.RS95: 
#               the 95% relative spread of the total randomness of each DV/BV 
#               measurement. 
# 
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#    ConfLevel: Sets level of confidence intervals (e.g. 0.95). 
# 
#      B1.null: sets null for testing B1. The usual value is 1.0. "Rejecting" 
#               this says there is some relationship between AS and DV/BV. So what? 
 
 
# Simulation results, per trial 
# ============================= 
 
#   B1.est: estimate of fold change in DV/BV from AS = 0 to ref.AS 
 
#    B1.lo: lower 95% confidence limit for B1. 
#    B1.hi: upper 95% confidence limit for B1. 
# 
#  p.value: one-sided p.value for testing 
#             Ho: B1 = B1.null 
#             Ha: B1 > B1.null 
 
 
DV.BVcurve = function( 
   title="a case with no title", 
   AS.pts,            # design points for Apparent Strain 
   AS.ref,            # reference design point for Apparent Strain 
   n,                 # number of donors used at each design point 
   B0,                # true geometric mean of DV/BV at AS = 0, gmean(0) 
   B1,                # true gmean(ref.AS)/gmean(0) 
   TotalNoise.RS95,   # the 95% RS of the total randomness of each DV/BV 
measurement. 
   ConfLevel=0.95,    # level of confidence interval 
   B1.null=1,         # sets null for testing B1 
   Print=TRUE,        # set to FALSE to suppress printing 
   Plot=TRUE,         # set to FALSE to suppress plotting of Trial 1 data 
   LogScaleDV.BV=F,   # set to TRUE to log scale DV/BV axis 
   NewWindow=TRUE,    # set to FALSE to re-use the same plot window 
   seed=1234955,      # a seed to start simulations 
   Ntrials=1000)      # number of trials in simulations 
  { 
     
  if (Print) { 
    cat("\n\n",title,"\n") 
    cat("\nDesign Points:", AS.pts) 
    cat("\nRefefence Point:", AS.ref, "\n") 
    cat("\nn:", n, "\n\n") 
    print(data.frame(B0, B1, TotalNoise.RS95),row.names="") 
    cat("\n") 
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    print(data.frame(ConfLevel,B1.null,row.names="")); cat("\n") 
    print(data.frame(Print,seed,Ntrials,row.names="")); cat("\n") 
    print(data.frame(Plot,LogScaleDV.BV,NewWindow,row.names="")); cat("\n")   
  } 
   
  set.seed(seed) 
  logB1.est <- p.value <- RelSpanCI <- rep(NA,Ntrials) 
  logB1.CLims <- matrix(NA, nrow=Ntrials, ncol=2) 
  K <- length(AS.pts) 
  Ntotal <- sum(n) 
     
  if (min(c(B0, B1, TotalNoise.RS95)) <= 0) { 
    stop ("B0, B1, TotalNoise.RS95 must be positive.") 
    } 
   
  if (TotalNoise.RS95 <= 1) { 
   stop ("TotalNoise.RS95 must exceed 1.0.") 
  } 
 
  SD.logTNoise <- log(TotalNoise.RS95)/(1.96*2) 
 
  DV.BV <- rep(NA, Ntotal) 
  AS <- rep(AS.pts, n) 
  X.AS <- AS/AS.ref 
  logB0 <- log(B0) 
  logB1 <- log(B1) 
   
  logB1.est <- logB1.CIlo <- logB1.CIhi <- B1.pvalue <- rep(NA, Ntrials) 
   
  logB1.null <- log(B1.null) 
  dfE <- Ntotal - 2 
   
  for (iTrial in 1:Ntrials)  { 
    logDV.BV <- logB0 + X.AS*logB1 + rnorm(Ntotal, 0, SD.logTNoise) 
    DV.BV <- exp(logDV.BV) 
     
    fit <- lm(logDV.BV ~ X.AS) 
    logB1.est[iTrial] <- fit$coefficients[2] 
    logB1.CLims[iTrial,] <- confint(fit, level=ConfLevel)[2,] 
    SE.B1 <- summary(fit)$coefficients[2,2] 
    t.stat <- (fit$coefficients[2] - logB1.null)/SE.B1 
    B1.pvalue[iTrial] <- pt(abs(t.stat), dfE, lower.tail = FALSE)  # one-sided 
        
    if (Print & (iTrial==1)) { 
        cat("\n\nFirst specimen in first trial\n") 
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        print (data.frame(AS, X.AS, DV.BV=round(exp(logDV.BV),3))) 
        cat("\n") 
        print(summary(fit)) 
    } 
     
    if (Plot & (iTrial==1)) {  # plot Trial 1 data 
     X <- seq(0,100)/(100/max(AS)) 
     Y <- exp(fit$coefficients[1] + (X/AS.ref)*fit$coefficients[2]) 
     plottitle <- "Data and Fit for Trial #1" 
     if (NewWindow) { 
        try(windows(width=6, height=4), silent=T) 
        try(quartz(width=6, height=4), silent=T) 
      } 
     
     Ymin <- 0 
     LogScaling = "" 
     Ylabel <- "Damaged Volume Fraction (DV/BV)" 
     Xmax <- max(AS) 
     Ymax <- max(DV.BV) 
      
     if (LogScaleDV.BV) { 
      LogScaling = "y" 
      DV.BV[DV.BV < 0.001] = 0.001 
      Ymin <- min(0.001, min(DV.BV)) 
      Ylabel <- "Damaged Volume Fraction (DV/BV; log-scaled)" 
      } 
 
      plot(DV.BV ~ AS, 
       ylim= c(Ymin, Ymax), 
        xlim= c(0, Xmax), 
       ylab=Ylabel, 
       xlab = "Apparent Strain (%)", 
        pch = "o",  
       xaxt="n", 
       log=LogScaling, 
       las=1, 
       cex.axis= 0.75, cex.lab=0.85, 
       main=plottitle) 
         axis(1, at=c(0, 0.5, 1, 1.5, 2, 2.5), cex.axis=0.75) 
         lines(X,Y) 
         } 
    } # end for (iTrial in 1:Ntrials) 
   
  B1.pvalue.char <- as.character(round(B1.pvalue, 4)) 
  B1.pvalue.char[B1.pvalue < 0.0001] <- "<0.0001" 
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  if (Print) { 
  cat("\n\nResults for first 10 trials\n") 
 
  first10 <- data.frame(B1.est=round(exp(logB1.est),3), 
                        B1.CLimLo=round(exp(logB1.CLims[,1]),3), 
            
 B1.CLimHi=round(exp(logB1.CLims[,2]),3), 
            
 pvalue=B1.pvalue.char, 
                        CIspan=round(exp(logB1.CLims[,2] - 
                         logB1.CLims[,1]),3))[1:10,] 
  print(first10) 
  } 
   
# Preliminary code to analyze the simulation study 
{ 
  cat("\n\nSummary of B1 estimates; true =", B1, "\n") 
  print(round(exp(summary(logB1.est)),2)) 
  cat("\n\nSummary of B1 lower confidence limits\n") 
  print(round(exp(summary(logB1.CLims[,1])),2)) 
  cat("\n\nSummary of B1 upper confidence limits\n") 
  print(round(exp(summary(logB1.CLims[,2])),2)) 
  cat("\n\nSummary of CI span = B1.CIhi/B1.CIlo\n") 
  print(round(exp(summary(logB1.CLims[,2] - 
   logB1.CLims[,1])),2)) 
  cat("\n\nSummary of B1 p.values; one-sided test of B1 > ", B1.null, "\n") 
  print(summary(B1.pvalue,3)) 
} 
   
} # end DV.BVcurve ()
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